an analysis of the clinical outcomes in 66 patients with hairy cell leukemia treated with pentostatin under the special exception mechanism of the division of cancer treatment , national cancer institute , between 1983 and 1987 has revealed a favorable balance of risk and benefit .
C0023443
hairy cell leukemia
C0030896
pentostatin